Please upgrade your browser.
See which players are teaming up to help in PSU Uplifting Athletes' fight against kidney cancer. There are 24 teams of four, and you can check out all of them right here.
A molecule that uses a cellular recycling process called autophagy to kill cancer cells has been identified by Stanford University researchers.
From NPR's Morning Edition: A researcher has found a potential new therapy for patients with kidney cancer, which historically hasn't responded well to treatments such as radiation and chemotherapy.
(PressZoom) - STANFORD, Calif. Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ. But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells. Ideally, the researchers said, a drug created from this molecule would help fight the life-threatening disease while leaving patients kidneys intact. Source: PressZoom
ImmunoGen, Inc. IMGN today announced the start of patient dosing in a Phase I clinical trial evaluating the Companys IMGN388 targeted anticancer compound for the treatment of solid tumors.
This study is one of the first to identify a trait unique to a certain form of cancer -- in this case, kidney cancer's deficient VHL gene -- and exploit it to defeat the disease,
The team, led by Prof David Cheresh of the University of California, San Diego, showed this way to ensure toxic chemotherapy is delivered precisely where it is needed had "a profound impact on metastasis in pancreatic and kidney cancer in mice."
A cancer patient sent home to die by the National Health Service has seen his health improve after he cashed in his pension and used funds raised by friends to pay privately for an expensive drug.
A team of researchers led by Christopher Wood of the Anderson Cancer Center in Houston, Texas gave the vaccine, called vitespen or Oncophage, to 409 patients whose cancerous tumours had been removed.
A judge has asked an NHS panel to reconsider its decision to refuse a powerful cancer drug to a woman who is the sole carer of her seriously ill husband.
|NeonCRM by Neon One|